AHSP Polyclonal Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Act as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia.
Synonyms
AHSP; AHSP_HUMAN; Alpha hemoglobin stabilizing protein; Alpha-hemoglobin-stabilizing protein; EDRF; ERAF; Erythroid associated factor; Erythroid dferentiation associated factor; Erythroid dferentiation related factor; Erythroid dferentiation-related factor; Erythroid-associated factor.
Host
Rabbit
Cross Reactivity
Human
Immunogen
1-80/102
Target
AHSP
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human AHSP/ERAF
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15321142 1 Vial
Lentiviral human ATP6V0E1 shRNA (UAS) - Lentiviral human ATP6V0E1 shRNA (UAS) plasmid
Sign In for Pricing
View Details